| BEN |
Report |
Adj. EPS (Q3 FY26) |
BEAT |
pred ~$0.70 vs. cons $0.658 |
HIGH |
| BEN |
Report |
LT Net Flows (Q3 FY26) |
BEAT |
pred ~$19B vs. cons $18.0B |
MEDIUM |
| BEN |
Report |
Alt Net Flows (Q3 FY26) |
BEAT |
pred ~$10.5B vs. cons $9.5B |
MEDIUM |
| BEN |
Guide |
FY26 Implied EPS (FY2026) |
BETTER |
guide ~$2.85-2.90 vs. cons $2.810 |
MEDIUM |
| BEN |
Guide |
Alt Fundraising Target (FY2026) |
BETTER |
guide >$32-35B vs. cons $35.2B |
MEDIUM |
| BEN |
Guide |
Operating Margin (FY2026) |
UNCHANGED |
guide high 27s / Q4 high 29s reiterated vs. cons ~27.4% |
HIGH |
| BEN |
Return |
Day-1 residual (stock − beta × S&P 500) |
+2.0% |
— |
MEDIUM |
| BEN |
Return |
5-day cumulative residual |
+3.0% (STABILIZE) |
STABILIZE — beat+raise partially priced in; sell-side estimate revisions provide follow-through but the stock's +12.6% post-earnings run limits upside; expect modest positive drift as FY estimates revised up, then stabilization |
MEDIUM |